Effects of Botulinum Toxin A on the Contractile Function of Dog Prostate

European Urology

Volumn 52, Issue 2, 2007, Pages 582-589

  Lin, Alex Tong Long ^a   Yang, An Hang ^a,b   Chen, Kuang Kuo ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Benign prostate hyperplasia; Botulinum toxin A; Prostate

Indexed keywords

BOTULINUM TOXIN A; NITRIC OXIDE; NORADRENALIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; SMOOTHELIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATROPHY; BATH; CELL VACUOLE; CLINICAL STUDY; CONTROL GROUP; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG SAFETY; ELECTROSTIMULATION; EVALUATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRESSURE; PRIORITY JOURNAL; PROSTATE; SMOOTH MUSCLE FIBER; STROMA; URETHRA;

ANIMALS; BOTULINUM TOXIN TYPE A; DISEASE MODELS, ANIMAL; DOGS; ELECTRIC STIMULATION; MALE; NEUROMUSCULAR AGENTS; NOREPINEPHRINE; PROSTATE; TENSILE STRENGTH;

EID: 34250722191     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.002     Document Type: Article

References (26)

1. Harris G., Dawson E., and Lee J. Botulinum toxin to the lateral rectus for the treatment of esotropia with paradoxical diplopia. Strabismus 9 (2001) 79-82
2. Sarrabayrouse M.A. Indications and limitations for the use of botulinum toxin for the treatment of facial wrinkles. Aesthetic Plast Surg 26 (2002) 233-238
3. Schulte-Baukloh H., Weiss C., Stolze T., et al. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 48 (2005) 984-990
4. Schmid D.M., Sauermann P., Werner M., et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 (2006) 177-185
5. Jain S., Tamer S.K., and Hiran S. Botulinum toxin as therapeutic agent in local hyperhydrosis. J Assoc Physicians India 50 (2002) 273-274
6. Swartling C., Naver H., Lindberg M., and Botulinum. A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 8 (2001) 247-252
7. Jongerius P.H., Joosten F., Hoogen F.J., et al. The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 113 (2003) 107-111
8. Porta M., Gamba M., Bertacchi G., et al. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 70 (2001) 538-540
9. Nadelhaft I. Cholinergic axons in the rat prostate and neurons in the pelvic ganglion. Brain Res 989 (2003) 52-57
10. Dixon J.S., Jen P.Y., and Gosling J.A. The distribution of vesicular acetylcholine transporter in the human male genitourinary organs and its co-localization with neuropeptide Y and nitric oxide synthase. Neurourol Urodyn 19 (2000) 185-194
11. Doggweiler R., Zermann D.H., Ishigooka M., et al. Botox-induced prostatic involution. Prostate 37 (1998) 44-50
12. Kuo H.C. Prostate botulinum A toxin injection-an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 65 (2005) 670-674
13. Chuang Y.C., Giannantoni A., and Chancellor M.B. The potential and promise of using botulinum toxin in the prostate gland. BJU Int 98 (2006) 28-32
14. Seki N., Nishiye E., Itoh T., et al. Electrical and mechanical properties of the capsular smooth muscles of the rabbit prostate in relation to the actions of the alpha 1-adrenoceptor blocker, YM-12617. Br J Pharmacol 93 (1988) 702-714
15. Furuya S., Kumamoto Y., Yokoyama E., et al. Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 128 (1982) 836-839
16. Lin A.T., Chen M.T., Chiang H., et al. Effect of orchiectomy on the alpha adrenergic contractile response of dog prostate. J Urol 154 (1995) 1930-1933
17. Chuang Y.C., Tu C.H., Huang C.C., et al. Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol 6 (2006) 12
18. MacKenzie I., Burnstock G., and Dolly J.O. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7 (1982) 997-1006
19. Smith C.P., Franks M.E., McNeil B.K., et al. Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 169 (2003) 1896-1900
20. Leippold T., Reitz A., and Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 44 (2003) 165-174
21. Hassan S.M., Jennekens F.G., and Veldman H. Botulinum toxin-induced myopathy in the rat. Brain 118 (1995) 533-545
22. Lannergren J., Westerblad H., and Bruton J.D. Dynamic vacuolation in skeletal muscle fibres after fatigue. Cell Biol Int 26 (2002) 911-920
23. James A.N., Ryan J.P., and Parkman H.P. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol 285 (2003) G291-G297
24. Ji J., Salapatek A.M., Lau H., et al. SNAP-25, a SNARE protein, inhibits two types of K channels in esophageal smooth muscle. Gastroenterology 122 (2002) 994-1006
25. Morris J.L., Jobling P., and Gibbins I.L. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281 (2001) H2124-H2132
26. Chuang Y.-C., Yoshimura N., Wu M., et al. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur Urol 51 (2007) 1119-1127